These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 20187020)
1. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020 [TBL] [Abstract][Full Text] [Related]
2. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics. Campbell MJ Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038 [No Abstract] [Full Text] [Related]
3. The potential for bias in reporting of industry-sponsored clinical trials. Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037 [TBL] [Abstract][Full Text] [Related]
4. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]
5. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mansi BA; Clark J; David FS; Gesell TM; Glasser S; Gonzalez J; Haller DG; Laine C; Miller CL; Mooney LA; Zecevic M Mayo Clin Proc; 2012 May; 87(5):424-9. PubMed ID: 22560521 [No Abstract] [Full Text] [Related]
6. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
7. [Publication ethics: regulation of financial conflicts of interests in medical journals]. Kakuk P Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379 [No Abstract] [Full Text] [Related]
8. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044 [TBL] [Abstract][Full Text] [Related]
9. Making available information from studies sponsored by the pharmaceutical industry: some current practices. O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036 [TBL] [Abstract][Full Text] [Related]
10. How pharmaceutical industry funding affects trial outcomes: causal structures and responses. Sismondo S Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169 [TBL] [Abstract][Full Text] [Related]
11. Research dishonesty and conflict of interest. Frizelle F N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259 [No Abstract] [Full Text] [Related]